These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11237176)

  • 1. Recent studies on the biofunctions and biotransformations of curcumin.
    Lin JK; Pan MH; Lin-Shiau SY
    Biofactors; 2000; 13(1-4):153-8. PubMed ID: 11237176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of cancer chemoprevention by curcumin.
    Lin JK; Lin-Shiau SY
    Proc Natl Sci Counc Repub China B; 2001 Apr; 25(2):59-66. PubMed ID: 11370761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin.
    Lin JK
    Arch Pharm Res; 2004 Jul; 27(7):683-92. PubMed ID: 15356994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targets of curcumin.
    Lin JK
    Adv Exp Med Biol; 2007; 595():227-43. PubMed ID: 17569214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of curcumin through reduction and glucuronidation in mice.
    Pan MH; Huang TM; Lin JK
    Drug Metab Dispos; 1999 Apr; 27(4):486-94. PubMed ID: 10101144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of curcumin on tumorigenesis in mice.
    Huang MT; Newmark HL; Frenkel K
    J Cell Biochem Suppl; 1997; 27():26-34. PubMed ID: 9591190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Shogaol is more effective than 6-gingerol and curcumin in inhibiting 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice.
    Wu H; Hsieh MC; Lo CY; Liu CB; Sang S; Ho CT; Pan MH
    Mol Nutr Food Res; 2010 Sep; 54(9):1296-306. PubMed ID: 20336681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin and its major metabolites inhibit the inflammatory response induced by lipopolysaccharide: translocation of nuclear factor-κB as potential target.
    Zhao F; Gong Y; Hu Y; Lu M; Wang J; Dong J; Chen D; Chen L; Fu F; Qiu F
    Mol Med Rep; 2015 Apr; 11(4):3087-93. PubMed ID: 25502175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages.
    Pan MH; Lin-Shiau SY; Lin JK
    Biochem Pharmacol; 2000 Dec; 60(11):1665-76. PubMed ID: 11077049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation.
    Chun KS; Keum YS; Han SS; Song YS; Kim SH; Surh YJ
    Carcinogenesis; 2003 Sep; 24(9):1515-24. PubMed ID: 12844482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular mechanisms for the antitumorigenic effect of curcumin.
    Leu TH; Maa MC
    Curr Med Chem Anticancer Agents; 2002 May; 2(3):357-70. PubMed ID: 12678737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant and anti-inflammatory properties of curcumin.
    Menon VP; Sudheer AR
    Adv Exp Med Biol; 2007; 595():105-25. PubMed ID: 17569207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses.
    Aggarwal BB; Deb L; Prasad S
    Molecules; 2014 Dec; 20(1):185-205. PubMed ID: 25547723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
    Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
    Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin: from food spice to cancer prevention.
    Oyagbemi AA; Saba AB; Ibraheem AO
    Asian Pac J Cancer Prev; 2009; 10(6):963-7. PubMed ID: 20192567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems.
    Gafner S; Lee SK; Cuendet M; Barthélémy S; Vergnes L; Labidalle S; Mehta RG; Boone CW; Pezzuto JM
    Phytochemistry; 2004 Nov; 65(21):2849-59. PubMed ID: 15501252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
    Moon Y; Glasgow WC; Eling TE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism.
    Lee HS; Lee MJ; Kim H; Choi SK; Kim JE; Moon HI; Park WH
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):720-9. PubMed ID: 20163327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin.
    Lin JK; Chen YC; Huang YT; Lin-Shiau SY
    J Cell Biochem Suppl; 1997; 28-29():39-48. PubMed ID: 9589348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays.
    Inano H; Onoda M; Inafuku N; Kubota M; Kamada Y; Osawa T; Kobayashi H; Wakabayashi K
    Carcinogenesis; 1999 Jun; 20(6):1011-8. PubMed ID: 10357781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.